Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

A promoter polymorphism rs2075824 within IMPA2 gene affecting the transcription activity: possible relationship with schizophrenia.

Li J, Huang S, Dai HR, Wang J, Lin LH, Xiao H, Peng X, Li F, Wang YP, Yuan JM, Li L.

J Cell Mol Med. 2017 Apr;21(4):658-664. doi: 10.1111/jcmm.13009. Epub 2016 Oct 17.

2.

Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures.

Arai R, Ito K, Ohnishi T, Ohba H, Akasaka R, Bessho Y, Hanawa-Suetsugu K, Yoshikawa T, Shirouzu M, Yokoyama S.

Proteins. 2007 May 15;67(3):732-42.

PMID:
17340635
3.

eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?

Carter CJ.

Schizophr Bull. 2007 Nov;33(6):1343-53. Epub 2007 Feb 27. Review.

4.

Molecular genetics of bipolar disorder and depression.

Kato T.

Psychiatry Clin Neurosci. 2007 Feb;61(1):3-19. Review.

5.

Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1.

Ohnishi T, Ohba H, Seo KC, Im J, Sato Y, Iwayama Y, Furuichi T, Chung SK, Yoshikawa T.

J Biol Chem. 2007 Jan 5;282(1):637-46. Epub 2006 Oct 26.

6.

Genetics of bipolar disorder.

Kato T, Kuratomi G, Kato N.

Drugs Today (Barc). 2005 May;41(5):335-44. Review.

PMID:
16082431
7.

C18orf1 located on chromosome 18p11.2 may confer susceptibility to schizophrenia.

Kikuchi M, Yamada K, Toyota T, Yoshikawa T.

J Med Dent Sci. 2003 Sep;50(3):225-9.

PMID:
15074360
8.

Genetic analysis of psychiatric disorders associated with human chromosome 18.

Kamnasaran D.

Clin Invest Med. 2003 Dec;26(6):285-302. Review.

PMID:
14690303
9.

Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples.

Yoshikawa T, Kikuchi M, Saito K, Watanabe A, Yamada K, Shibuya H, Nankai M, Kurumaji A, Hattori E, Ishiguro H, Shimizu H, Okubo Y, Toru M, Detera-Wadleigh SD.

Mol Psychiatry. 2001 Mar;6(2):202-10.

Supplemental Content

Loading ...
Support Center